Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Sagimet Biosciences Inc (NASDAQ: SGMT) closed at $8.89 in the last session, down -4.10% from day before closing price of $9.27. In other words, the price has decreased by -$4.10 from its previous closing price. On the day, 0.57 million shares were traded. SGMT stock price reached its highest trading level at $9.6 during the session, while it also had its lowest trading level at $8.75.
Ratios:
We take a closer look at SGMT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 20.26 and its Current Ratio is at 20.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on July 24, 2025, initiated with a Buy rating and assigned the stock a target price of $28.
On December 06, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $30.
On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $12.UBS initiated its Buy rating on November 12, 2024, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 21 ’25 when Happel David sold 65,478 shares for $9.13 per share. The transaction valued at 598,115 led to the insider holds 689,722 shares of the business.
Martins Eduardo Bruno sold 8,277 shares of SGMT for $75,607 on Jul 21 ’25. The Chief Medical Officer now owns 106,936 shares after completing the transaction at $9.13 per share. On Jul 21 ’25, another insider, Rozek Elizabeth, who serves as the General Counsel and CCO of the company, sold 10,780 shares for $9.13 each. As a result, the insider received 98,471 and left with 183,726 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 286216224 and an Enterprise Value of 141686624.
Stock Price History:
The Beta on a monthly basis for SGMT is 3.44, which has changed by 1.5545976 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, SGMT has reached a high of $11.41, while it has fallen to a 52-week low of $1.73. The 50-Day Moving Average of the stock is 22.29%, while the 200-Day Moving Average is calculated to be 76.76%.
Shares Statistics:
According to the various share statistics, SGMT traded on average about 1.56M shares per day over the past 3-months and 859030 shares per day over the past 10 days. A total of 30.67M shares are outstanding, with a floating share count of 23.86M. Insiders hold about 25.90% of the company’s shares, while institutions hold 36.20% stake in the company. Shares short for SGMT as of 1752537600 were 3378220 with a Short Ratio of 2.16, compared to 1749772800 on 3805939. Therefore, it implies a Short% of Shares Outstanding of 3378220 and a Short% of Float of 11.89.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
